Please login to the form below

Not currently logged in

MedImmune and Immunocore to join on melanoma trials

medimmune building

Will trial MEDI4736 in combination with tremelimumab

Ferring collaborates on novel IBD drug development

Project in partnership with Paris-based Institut Pasteur

Survey reveals problems with lung cancer mutation testing

Successful PartnershipsA quarter of patients surveyed not receiving EGFR testing prior to treatment

Merck files Keytruda for lung cancer

merck-keytruda-pembrolizumab-melanomaFiled to the FDA as a treatment option for NSCLC patients

AZ and Takeda drugs should carry heart failure warning

FDA headquarters White OakFDA panel claim diabetes drugs Onglyza and Nesina need label updates

Quality in Care Hepatitis C programme open for entry

QiC Hepatitis C NHS TaysidePMGroup's QiC programme aims to recognise best practice in care for hepatitis C in the UK

BMS gives Erbitux rights to Lilly in the US

Erbitux - Merck KGaAFirm wants to focus on its burgeoning PD-1 cancer range

First generic version of Teva’s Copaxone cleared by FDA

Teva CopaxoneWill be marketed as Glatopa by Momenta and Novartis’ Sandoz subsidiary

Pfizer breast cancer drug shines in latest trial

Pfizer headquartersStudy with Ibrance stopped early because of its success

Mission Critical

When it’s lonely at the top, leaders can seek a critical friend

Latest appointments

Featured jobs

Subscribe to our email news alerts


Add my company

Reynolds-MacKenzie is the multi award-winning specialist public relations practice within OPEN Health; the first ever agency in the health communications...

Latest intelligence

Rise of generics will curb France’s pharma growth
Generics are set to take a serious bite out of the market as a cash-strapped government pushes for cost controls...
How to account for different motivations in closed loop marketing
While your CLM technology might be brand new, the communications strategy behind should be tried and tested. In fact one of the earliest exponents of rhetoric, Aristotle, can still inform...
Framing, provocation, and truth
It all depends on how you ask the question…...